Substrate specificity of prostate-specific antigen (PSA)  by Coombs, Gary S et al.
Research Paper 475 
Substrate specificity of prostate-specific antigen (PSA) 
Gary S Coombsi, Robert C Bergstrom *, Jean-Luc Pellequer3, Scott I Baker*, 
Marc Navre4, Matthew M Smith4, John A Tainer3, Edwin L Madison’ and 
David R Corey* 
Background: The serine protease prostate-specific antigen (PSA) is a useful 
clinical marker for prostatic malignancy. PSA is a member of the kallikrein sub- 
group of the (chymo)trypsin serine protease family, but differs from the 
prototypical member of this subgroup, tissue kallikrein, in possessing a 
specificity more similar to that of chymotrypsin than trypsin. We report the use 
of two strategies, substrate phage display and iterative optimization of natural 
cleavage sites, to identify labile sequences for PSA cleavage. 
Results: Iterative optimization and substrate phage display converged on the 
amino-acid sequence SS(Y/F)Y&(G/S) as preferred subsite occupancy for 
PSA. These sequences were cleaved by PSA with catalytic efficiencies as high 
as 2200-3100 M-1 s-1, compared with values of 2-46 M-l s-l for peptides 
containing likely physiological target sequences of PSA from the protein 
semenogelin. Substrate residues that bind to secondary (non-Sl) subsites have 
a critical role in defining labile substrates and can even cause otherwise 
disfavored amino acids to bind in the primary specificity (Sl) pocket. 
Conclusions: The importance of secondary subsites in defining both the 
specificity and efficiency of cleavage suggests that substrate recognition by 
PSA is mediated by an extended binding site. Elucidation of preferred subsite 
occupancy allowed refinement of the structural model of PSA and should 
facilitate the development of more sensitive activity-based assays and the 
design of potent inhibitors. 
Introduction 
Prostate specific antigen (PSA) is a (chymo)trypsin family 
serine protease that was first found in human semen [1,2]. 
PSA can also be detected in serum, where elevated levels 
have been correlated with benign and metastatic disease, 
making PSA a useful marker for the growth of prostatic 
tumors [3-51. Clinical determination of PSA levels currently 
relies exclusively on immunoassays that do not discriminate 
between active PSA, PSA zymogen, or inactive complexes 
of PSA with circulating serpins such as Gantichymotrypsin. 
Identification of easily detectable substrates for PSA would 
allow localization and quantitation of active forms of this 
enzyme, information that is likely to provide new insights 
into the biological and pathological roles of PSA. 
Proposed native substrates for PSA include semenogelin 
[6-S], the predominant protein component of the coagu- 
lum that forms upon ejaculation and must be digested to 
permit sperm motility. PSA has also been observed to 
cleave insulin growth-factor-binding protein-3 [9,10], 
fibronectin and laminin [ll], as well as parathyroid- 
hormone-related protein [la]. Cleavage of these substrates 
suggests that PSA could have a direct role in cancer cell 
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proliferation and invasion. Selective inhibition of PSA, 
therefore, might have important physiological conse- 
quences, and development of efficient inhibitors would 
allow the hypothesis that improper PSA expression stimu- 
lates the growth of prostate tumors to be tested. 
PSA shares approximately 78% identity with human glan- 
dular kallikrein (hK2) and 62% identity with human pan- 
creatic kallikrein (hK1) [2,13-1.51. Catalysis by PSA has 
been characterized qualitatively through the hydrolysis of 
peptides and complete digestion of semenogelin revealing 
that, unlike hK2 and tissue kallikrein, which possess 
trypsin-like specificity for arginine and lysine, PSA pos- 
sesses a chymotrypsin-like preference for tyrosine and 
leucine [6,7,16,17]. More recently, Isaacs and coworkers 
[18] have synthesized fluorogenic substrates containing 
7-amino-4methyl-coumarin leaving groups that are 
cleaved with k,,,/K, values of up to 270 M-l s-l. These 
investigators have also characterized less efficient sub- 
strates that display selectivity towards PSA relative to other 
proteases, and have demonstrated that PSA possesses a 
surprising ability to use glutamine as a Pl residue 
(Figure 1) during cleavage of activated substrates [18]. 
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Nomenclature for the interaction of substrate amino acids with 
protease subsites [56]. 
In this study we define the preferred subsite occupancy 
for peptide cleavage by PSA. Using two independent 
methods, substrate phage display [19,20] and iterative 
optimization of native substrate sequences [‘21,22], we 
have identified and kinetically characterized reactive 
peptide substrates for PSA containing the P4 to. PZ’ 
residues SS(F/Y)Y&(G/S) (using single-letter amino acid 
code; the arrow denotes the position of peptide-bond 
hydrolysis). Definition of this specificity is a first step 
towards the design of readily detectable substrates and 
potent inhibitors, and offers insights into substrate dis- 
crimination by PSA. Similar to urokinase plasminogen 
activator (u-PA) [23] and tissue-type plasminogen activa- 
tor (t-PA) [24], PSA appears to have a narrow specificity 
for optimal occupancy of non-S1 subsites that is- in contrast 
to the broad specificity exhibited by related enzymes such 
as trypsin or chymotrypsin. Knowledge of preferred 
subsite occupancy for peptide substrates encouraged 
refinement of the three-dimensional model of PSA [ZS], 
primarily by remodeling the conformation of residues in 
PSA corresponding to the kallikrein loop. 
Results and discussion 
Kinetics of hydrolysis of peptides modeled after native 
cleavage sites and interchange of Pl residues 
We initiated our studies by examining PSA-mediated 
cleavage of peptides I and II (Table 1) derived from 
cleavage sites within semenogelin identified by Lilja et&. 
[17]. For these studies we employed purified PSA from 
semen. Davie and coworkers [26] have noted that such 
preparations can contain proteolytic contaminants that 
might affect kinetic analysis, and kallikrein hK2, a pro- 
tease specific for Pl arginine has been directly implicated 
as a contaminant in some PSA preparations [27]. 
Although the presence of contaminating enzyme activity 
can never be completely ruled out we do not believe that 
this affected our assays because, with the exception of one 
Table 1 
Iterative optimization of peptide hydrolysis. PSA-mediated 
hydrolysis of peptides derived from labile sequences within 
semenogelin. 
Substrate 
*(Pn ,... P3, P2, Pl JPl’, P2’, P3’,... Pn’) (3) &) (y& 
Sequences from semenogelin 
I GSQQLLJHNKQEGRD 0.012 5900 2.0 
II GISSQYkNTEERLW 1.30 28000 46 
Exchange of P7 residues between I and II 
III GSQQLYhNKQEGRD 0.037 14000 2.6 
IV GISSQLkNTEERLW 0.0035 2300 1.5 
Substitution of P2 residues within II 
V GISSGYhNTEERLW 0.13 1900 70 
VI GISSAYkNTEERLW 0.30 290 1000 
VII GISSPYJSNTEERLW 1.1 10000 110 
VIII GISSFYkNTEERLW 2.3 1300 1800 
Substitutions of Pl’and f2’in VIII 
IX GISSFYJGNTEERLW 0.75 490 1500 
X GISSFYhNTEERLW 1.80 180 1000 
XI GISSFYJFNTEERLW ND 
XII GISSFYJQNTEERLW ND 
XIII GISSFYhGTEERLW 2.1 1100 1900 
XIV GISSFYhATEERLW 1.7 1100 1500 
xv GISSFYkSTEERLW 1.7 790 2200 
*Positional nomenclature of subsite residues. Arrows denote the 
position of peptide-bond hydrolysis. The peptide bond is cleaved 
between Pl and Pl’. ND, not determined due to insolubility of 
substrate peptides. Calculated error values were between 6 and 26%. 
series of peptide substrates (noted below), cleavage was 
only observed adjacent to Pl leucine and tyrosine 
residues, a preference seen during extensive digestion of 
semenogelin [7]. In addition, Davie and coworkers [26] 
noted that recombinant PSA cannot readily cleave the 
Leu-Cys(SOJ bond in insulin p chain, a finding that con- 
trasts with an earlier report [16] that PSA derived from 
seminal plasma could rapidly cleave this bond. We found 
that the PSA used in our studies behaved similarly to 
recombinant PSA and did not cleave the Leu-Cys(S0,) 
bond (data not shown). 
We observed that peptide I, in which leucine was the Pl 
residue, was cleaved with a 23-fold lower catalytic effi- 
ciency, k,,dK,, than peptide II (Table l), in which tyro- 
sine was the Pl residue. We then exchanged tyrosine and 
leucine residues between I and II to yield peptides III and 
IV to test the relative importance of tyrosine versus 
leucine occupancy at the Pl position. 
Introduction of tyrosine did not substantially alter catalysis 
of III relative to I, whereas introduction of leucine 
reduced catalysis of IV relative to II by approximately 30- 
fold. The 18-fold difference in catalysis between tyrosine- 
containing peptides II and III demonstrated that residues 
other than Pl can influence the rate of hydrolysis and led 
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us to search for more labile substrates by systematically 
examining the effect of subsite occupancy on catalysis. 
Iterative substrate optimization 
To identify more labile substrates for PSA and to begin to 
develop rules for preferred subsite occupancy we modi- 
fied peptide II, the more reactive of the initial physiologi- 
cally relevant substrates, and kinetically assayed the 
resultant peptides (Table 1). The Pl tyrosine was held 
constant, but residues were substituted at the PZ, Pl’, and 
PZ’ positions. Substitution of the glutamine at P2 in 
peptide II by glycine, alanine, proline or phenylalanine 
improved catalysis by 1.5, 22, 2.4, and 39-fold, respec- 
tively, supporting an important role of PZ/SZ interactions 
in promoting efficient catalysis. Because introduction of 
phenylalanine at P2 yielded the most labile substrate, it 
was held constant during subsequent modifications at Pl’ 
and PZ’. Our ability to measure the effect of substitutions 
at Pl’ was limited by the insolubility of variant peptides 
Xl and XII. Substitution of alanine or glycine in place of 
serine at Pl’, and substitution of glycine, alanine or serine 
for asparagine at P2’ altered catalysis by less than twofold, 
with SSFY&S being the preferred P4-PZ’ sequence. 
Identification of potentially labile sequences using 
substrate phage display 
Iterative optimization is a useful approach for identifying 
peptides with improved reactivity relative to peptides 
derived from native cleavage sequences. It is not feasible 
to test all combinations of residues, however, because the 
number of peptide substrates that can be synthesized and 
assayed kinetically is limited. To further delineate amino- 
acid preferences for catalysis by PSA we therefore used 
substrate phage display [19,20] to identify labile 
sequences through library screening. To avoid biasing 
results, we employed iterative substrate optimization and 
substrate phage display independently and did not 
compare data regarding labile sequences prior to choosing 
candidate peptides for assay. 
For phage display, a polyvalent fd phage library that dis- 
played random octapeptide sequences was prepared. Each 
member of this library displayed an amino-terminal exten- 
sion from phage coat protein III that contained a four- 
residue flexible linker region (GGAG), a randomized region 
of eight amino acids, a six amino-acid linker sequence 
(GGAGSS), and the epitopes for mAbs 179 and 3-E7. The 
mAb epitopes serve as an affinity tag for removal of undi- 
gested phage and as a marker in a dot blot assay for moni- 
toring phage reactivity (see below). Incubation of phage 
with PSA did not affect infectivity of the phage, nor did 
PSA appear to cleave phage protein III, the antibody epi- 
topes or the flexible linker sequences. As a result, cleavage 
of the randomized eight amino-acid insert by PSA was 
required to remove mAb 179 and 3E-7 epitopes from an 
individual phage particle. Incubation of the library with 
PSA, followed by removal of phage retaining the antibody 
epitopes, therefore, accomplished a large enrichment of 
phage clones whose random octamer sequence was effi- 
ciently cleaved by PSA. 
Analysis of selected phage clones and identification of a 
consensus sequence 
Following five rounds of selection to enrich and amplify 
phage displaying sequences readily cleaved by PSA, 88 
phage clones were identified as PSA substrates (Table 2; 
Figure 2). Of the 88 sequences, 60 contained at least one 
tyrosine residue, and 41 sequences contained leucine. Ten 
sequences contained neither tyrosine nor leucine; seven of 
these ten sequences contained phenylalanine, and the 
remaining three sequences contained isoleucine, methion- 
ine or tryptophan. The widespread availability of tyrosine 
or leucine for Pl occupancy is in agreement with data from 
digestion of semenogelin, which shows that tyrosine and 
leucine are primarily used as Pl residues during hydrolysis 
of this physiologically relevant substrate [7,8]. 
Taken together, the substrate phage clones suggest the 
following consensus sequence for peptide substrates of 
PSA: P5 (G), P4 (A, G, S), P3 (S > T, A, R), PZ (Y > X), Pl 
(Y > L), Pl’ (A, S, T > Q), PZ’ (A, G, S > R), P3’ (A, G) 
(Figure Za) where X denotes similar preference for several 
other amino acids. Such analysis of subsite preference 
from phage display data is complicated by the fact that 
almost every putative P5 to P3’ sequence contains at least 
one residue from one of the two constant linker sequences 
(GGAG and GGAGSS), biasing the library towards con- 
taining serine, glycine or alanine. After removing these 
constant residues from the selected sequences, however, 
the consensus sequence that emerges is only slightly 
altered: P5 (R, L > X), P4 (S > A), P3 (S > A, R, T), PZ 
(Y > X), Pl (Y > L), Pl’ (S, T, A > Q), P2’ (S > A, R), P3’ 
(A, S) (Figure Zb), with glycine significantly less promi- 
nent at P.5, P4, PZ’, and P3’ but with other preferences 
unchanged. At the P2, Pl’, and P2’ positions, substitutions 
which produced highly active peptides during iterative 
optimization are well represented in the phage display 
data, whereas subsititutions that yield low activity sub- 
strates, such as glycine or proline at P2, are rarely found 
among the selected sequences. 
Dot blot ranking and refinement of the consensus sequence 
Dot blot analysis [23,24], in which phage are treated with 
PSA, blotted onto a nitrocellulose membrane, and detected 
by assaying the immunoreactivity of any uncleaved mAb 
epitopes, was performed to monitor digestion of all 88 
clones by PSA and to obtain an approximate ranking of 
their susceptibility to proteolysis. This procedure identifies 
those phage that are cleaved most rapidly and allows sub- 
sequent detailed kinetic assays to be focused on the most 
promising potential substrates. Under increasingly strin- 
gent assay conditions, nine of the 88 substrate phage 
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Table 2 
Alignment of the randomized regions of selected clones from substrate phage display. 
Clone P8 P7 P6 P5 P4 P3 P2 Pl Pl’ P2’ P3’ P4’ P5’ P6’ P7’ Clone P8 P7 P6 P5 P4 P3 P2 Pl Pl’ P2’ P3’ P4’ P5’ P6’ P7’ 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
SI LYGVSK 45 
HYSAVTRP 46 
PSSTFYRA 47 
LRLASTYS 48 
ASAFMRAV 49 
SLYTALEM 50 
LRSRMYTP 51 
YYTSPSPS 52 
RSVLHSSH 53 
PVRNRVLA 54 
RRASSLHA 55 
YPERSRFY 56 
AYYYTVRA 57 
YQSARPQS 58 
RKYLGFLR 59 
APRASVYS 60 
YYRAPDSA 61 
SYYVNTAT 62 
LARAHDAN 63 
LTGARLTS 64 
TSTSKLYA 65 
PISTFFTS 66 
TMYMSPFP 67 
TLRSAYAT 68 
FAHSSSYA 69 
RLYSMEVA 70 
FPPPRLYS 71 
VQSRYQL 72 
RPAAVYS 73 
KARNYMDA 74 
FQSSTMRT 75 
AFRSSLRS 76 
GSVSRAYR 77 
YSQLYYTS 78 
PLMKPLWA 79 
FYSSTGSE 80 
PYRTQLFA 81 
RSTSTVYT 82 
TSSFYHNP 83 
GLTAYYGT 84 
HPLSSFK 85 
NFPPFRRA 86 
PRLSQRYG 87 
NSLSRLMS 88 
LVRSSRRA 
FGSAAYQG 
NAQRSTYY 
TYRASHYS 
SIRSVYRCI 
SATMASPP 
RSRSRLFR 
YTVTKVYS 
YHVRRLGR 
PTARYSAA 
LPRTVMFG 
TLSLSSYY 
ALRGAMYA 
SRFSSYYT 
PFQTSLYS 
SSYQSRRL 
RLYSTLYS 
PLSRVQSA 
TRLARPYS 
WTRSSNYG 
STRASYTS 
SPRSAVIS 
YYGAFSRR 
S S R A A Y A 
RSVLFSAG 
WSAMYATS 
YYALGQPS 
FYAADELS 
LSRHYALP 
LSRLSSNP 
RWI RKAGS 
TTKHRFYT 
SAAAWFTA 
FVRRFTSG 
YYQTRFPT 
SGATSMYS 
VFLSRAYA 
YYGSASST 
PHARRYFS 
LHHSAYTF 
RAARLYTA 
SGLSALGS 
ATSTFQSS 
KKLSTHYA 
Alignments were made assuming a preference for tyrosine > leucine > other hydrophobic residues at Pl. Amino- and carboxyl-terminal residues 
flanking these sequences are contributed by the phage constant regions and are GGAG and GGAGSS respectively. 
appeared to be particularly labile and were selected for 
further analysis (Table 3). 
All nine sequences from the most labile phage contained a 
tyrosine residue that could act as a potential Pl residue. 
Assuming tyrosine as Pl, seven of nine contained a 
hydrophobic residue at P.S. Six of nine contained serine or 
threonine at P4, five of nine contained serine or threonine 
at P3, seven of nine contained a hydrophobic residue at P2, 
and five of nine contained serine at Pl’. Only two of the 
r&e clones had a randomized residue at PZ’, in both cases 
alanine. For the other seven, this residue was either a 
glycine (for six sequences) or an alanine (for the other 
sequence) contributed by the constant phage linker 
sequence adjacent to the epitope tag. Similarly, at P3’ 
seven of nine clones contained either a glycine (one 
sequence) or an alanine (six sequences) contributed by the 
linker region. The observation that randomized residues 
do not make a strong contribution to P2’ or P3’ suggests 
that either giycine and alanine are preferred at P2’ and P3’ 
or there is no strong preference for any residue at these 
positions and glycine and alanine are appearing by default. 
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Figure 2 
Putative P5 amino acid Putative P4 amino acid Putative P3 amino acid Putative P2 amino acid 
P3’ 
Putative Pl amino acid Putative Pl’ amino acid Putative P2’ amino acid 
Putative P5 amino acid Putative P4 amino acid Putative P2’ amino acid 
Putative P3’ amino acid 
Putative P3’ amino acid 
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Elucidation of the occupancy of P5-P3’ sites through substrate phage 
display. (a) P5-P3’ occupancy including residues contributed by the 
constant phage linker region. (b) P5, P4, P2’ and P3’ occupancy 
excluding residues contributed by the phage linker region. Occupancy 
of P3-Pl’ was similar regardless of whether residues contributed by 
the phage linker region were considered. P5-P3’ assignments were 
based on the assumption that occupancy of Pl by tyrosine or leucine 
was preferred. 
Seven out of nine clones contained randomized residues 
at P6 and P7, but no clear consensus emerged for these 
positions, which are expected to be solvent exposed when 
peptide is bound to protease. It might, however, be sig- 
nificant that glycine was not found at P7 in any of these 
clones, and occurred at P6 in only two clones, even 
though its presence in the constant region greatly 
increased the potential for glycine to occupy these posi- 
tions if it exerted a neutral effect. Thus, preferences for 
positions P7 to P3’ are P6/P7 (broad specificity, probably 
excluding glycine), P5 (hydrophobic), P4 (S > T, A), P3 
(S), P2 (Y >V, L), Pl (Y), Pl’ (S), P2’ (G > A), P3’ (A) 
with the caveat that P2’ and P3’ are biased by the identity 
of the constant linker region and might not exert a large 
effect on specificity. These results suggest a P4 to P2’ 
consensus of SSYYSG, a sequence strikingly similar to 
SSFYSS, the best sequence identified independently by 
alteration of a native sequence cleaved within 
semenogelin (Table 1) and consistent with the broader 
consensus obtained by analysis of all 88 substrate phage 
clones (Table 2). 
Kinetic analysis of the cleavage of peptides containing 
sequences present in selected substrate phage 
Six peptides containing amino-acid sequences present in 
the most labile phage and one peptide containing the con- 
sensus cleavage sequence SSYYSG were chosen for 
kinetic analysis to confirm the results obtained from phage 
display and to quantify catalysis of the putative cleavage 
sequences within selected phage (Table 4). All six 
selected peptides, W-XX, were cleaved with efficiencies 
greater than peptides I and II derived from semenogelin, 
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Table 3 Table 4 
Alignment of selected clones showing the highest reactivity 
towards PSA as determined by monitoring cleavage of intact 
phage by a dot blot assay. 
Clone P8 P7 P6 P5 P4 P3 P2 Pl Pl’ P2’ P3’ P4’ P5’ P6’ 
4 LRLASTYS 
16 APRASVYS 
17 YYRAPDSA 
52 YTVTKVYS 
54 PTARYSAA 
56 TLSLSSYY 
58 SRFSSYYT 
61 RLYSTLYS 
81 VFLSRAYA 
Alignments are made assuming preference for tyrosine > leucine at Pl. 
Amino- and carboxyl-terminal residues flanking these sequences are 
contributed by the phage constant regions and are GGAG and 
GGAGSS respectively. 
although, as will be discussed below, one peptide, XXI, 
was significantly less labile than the other selected 
sequences. Leaving aside XXI, the selected peptides were 
cleaved lo-33-fold more efficiently than tyrosine-contain- 
ing peptide II. Increases in catalytic efficiency were 
reflected in improved values for k,,, for four of these five 
substrates, and in decreased values for K, for all sub- 
strates. We also assayed cleavage of peptide XXII based 
on the conse..sus sequence from the selected peptides 
and observed that hydrolysis of XXII by PSA was more 
than twice as efficient as any one of the selected 
sequences. k,,JK, was 67-fold greater than that observed 
for peptide II despite the fact that II and XXIII share 
common P4, P3, Pl, and Pl’ residues. 
Influence of surrounding subsites on Pl occupancy 
As noted above, hydrolysis of peptide XXI containing the 
octamer sequence PTARYSAA was relatively inefficient 
with a catalytic efficiency of 76 M-l+, 6-l&fold less than 
that of the other selected sequences listed in Table 4. 
Surprisingly, high performance liquid chromatography 
(HPLC) purification of the cleaved peptide revealed two 
cleavage sites, and mass spectral analysis of the purified 
fragments indicated that the major product was due to 
cleavage after a Pl serine (PTARYSJAA), with a smaller 
amount of cleavage after the tyrosine we had expected to 
be the predominant Pl residue (PTARYLSAA) 
(Figure 3). We also observed a shift in specificity away 
from Pl tyrosine for peptides containing asparagine 
(PTARYJNAA) or glutamine (PTARYQLAA) rather than 
serine (data not shown). Cleavage after Pl glutamine was 
more efficient than cleavage after asparagine and was 
similar to cleavage after serine. The altered Pl specificity 
is reminiscent of the observation by Isaacs and colleagues 
[18] that glutamine can function as a Pl residue in the 
context of substrates containing activated amide bonds 
with 7-amino-4-methyl coumarin leaving groups. 
PSA-mediated hydrolysis of peptides identified by substrate 
phage display and related variants. 
Substrate 
*(Pn ,... P3, P2, Pl ,JPl’, P2’, P3’,... Pn’) (2) 
Km kc,t’Km 
(PM) (M-’ s-‘) 
XVI GAGAPRASVYkGAG 3.3 7100 460 
XVII GAGYYhAPDSAGAG 14 10000 1400 
XVIII GAGSRFSSYYJTGAG 5.1 4000 1300 
XIX GAGLRLASTYhGAG 2.0 4400 450 
xx GAGVFLSRAYd-AGAG 0.37 630 590 
XXI GAGPTARYShAGAG 0.44 5800 76 
XXII GAGLRLSSYYJSGAG 0.83 270 3100 
XXIII GAGLRLSSBYhGAG <5.0 >38000 130 
XXIV GAGLRLSSRYh@G ~3.8 >26000 150 
XXVIII GAGPTAKYShAGAG 0.70 6500 110 
*Positional nomenclature of subsite residues. Arrows denote the 
position of peptide bond hydrolysis as identified by mass spectral 
analysis. Peptide XXI is also cleaved after tyrosine, but the kinetics 
shown are obtained through monitoring initial rates of reaction after 
serine and prior to evolution of significant product from cleavage after 
tyrosine, Underlined amino acids in XXII and XXIV are changes 
relative to parent peptide XXII. Calculated error values were between 
7 and 23%. 
To investigate the origin of this unexpected shift in Pl 
specificity from tyrosine to serine for cleavage of XXI, we 
inserted residues found in peptide XXI into the P5, P’Z, 
and P’Z’ positions (based on cleavage at tyrosine at Pl) of 
peptide XXII that contained the consensus sequence for 
efficient cleavage by PSA. Insertion of arginine adjacent to 
tyrosine to create peptide XXIII caused a greater than 
140-fold increase in K,, from 270 PM to greater than 
38 mM (Table 4), and a reduction of overall catalytic effi- 
ciency, k,,,/K,, of approximately 24-fold. As with parent 
peptide XXII, the predominant cleavage products for 
peptide XXIII were derived from cleavage after tyrosine. 
A measurable amount of products was also detected due to 
cleavage after serine, however (Figure 4a). Peptide XXIV, 
in which arginine and alanine were substituted for P2 tyro- 
sine and P2’ glycine respectively, was also cleaved ineffi- 
ciently by PSA and produced increased levels of cleavage 
after the serine. The additional substitution of proline for 
leucine to generate peptide XXV made serine the primary 
P 1 residue (Figure 4a). 
The gradual alteration of Pl specificity of peptides 
XXII-XXV from tyrosine to serine demonstrated that the 
introduction of non-P1 point mutations into consensus 
peptide XXII not only affected the rate at which PSA 
hydrolyzed variants of peptide XXII but also significantly 
influenced the selection of a Pl residue for this family of 
peptides. To probe further the molecular determinants 
that contributed to shifting the specificity of PSA for sub- 
strate Pl residues, we performed the converse experiment 
by attempting to shift the Pl specificity of PSA for 
peptide XXI containing the P6-PZ’ sequence PTARYSAA 
from preferring serine as a Pl residue to preferring a Pl 
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Figure 3 
Ii la) i Peak a: Intact peptide 
I GAGPTARYSAAGAG 
Peak b: Cleavage product Pl Ser (SL) 
GAGPTARYSi 
Retention time Peak c: Cleavage product Pl Tyr (Yl) 
b) mw=QQO 
Mass (m/z) 
GAGPTARYJ 
cl 
mm=793 
7 I- 
SO0 800 1001 
Mass h/z) 
0 
Chemistry & Biolog) 
Shift of Pl selectivity for digestion of peptide XXI. (a) HPLC 
chromatogram of cleavage of peptide XXI containing the sequence 
PTARYSAA showing three peaks. Peak a corresponds to intact 
peptide, peak b to cleavage after Pl serine and peak c to cleavage 
after Pl tyrosine. (b) Mass spectral data for fragment b. (c) Mass 
spectral data for fragment c. 
!I 
tyrosine. Two different point mutations in peptide XXI 
achieved this goal (Figure 4b). Replacement of the proline 
in peptide XXI with a leucine residue yielded peptide 
XXVI, which was preferentially cleaved by PSA using 
tyrosine as a Pl residue rather than serine. Substitution of 
a tyrosine for the arginine in XXI created peptide XXVII, 
which was also cleaved by PSA almost entirely by using 
tyrosine as a Pl residue. 
These data reveal that occupancy of the S2 subsite by argi- 
nine is strongly disfavored by PSA. To determine if this 
was due to positive charge we synthesized peptide 
XXVIII, which contains a lysine at the analogous position 
of arginine in XXI. Similar to cleavage of XXI, peptide 
XXVIII is hydrolyzed slowly by PSA and exhibits a shift in 
preferred Sl occupancy from tyrosine to serine (Table 4), 
suggesting that the presence of positively charged residues 
adjacent to tyrosine encourages a substrate-binding mode 
Figure 4 
I’ 
L 
a) (W rr XXII GAGLRLSSYYkGAG XXI GAGPTARYiSlAAGAG XXIIIGAGLRLSSRYk&GAG XXVI GAGLTARYkJAAGAG r XXIV GAGLRLSSiiY&&AG XXVIIGAG~TAXYk4?iGAG rXXV GAGLR_PSSRY&&AG 
b a 
/ 
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Shift of Pi selectivity during interchange of residues between peptides 
XXI and XXII and complete digestion by PSA. (a) Introduction of 
residues from peptide XXI into peptide XXII and HPLC monitoring of 
digestion by PSA. (b) Introduction of residues for peptide XXII into 
peptide XXI. Peak a denotes cleavage after Pl tyrosine. Peak b 
denotes cleavage after Pl serine. The identity of the Pl residue was 
determined by mass spectrometry. Underlined residues were 
introduced into the peptide XXI or XXII. 
in which tyrosine occupies the $2 subsite rather than the 
Sl subsite. We note that both iterative subsite optimization 
(Table 1) and substrate phage display (Table 2) suggest 
that S2 occupancy by tyrosine is preferred, a characteristic 
that probably works to promote productive occupancy of 
the Sl subsite by adjacent residues. Although disfavored 
occupancy of the S2 subsite by lysine or arginine is suffi- 
cient to produce some shifting of Sl preferences, the shift 
of Sl selectivity seen with peptides XXIV and XXV 
demonstrates that subsite interactions beyond Sl and S2 
affect peptide bond cleavage. Both glycine to alanine and 
leucine to proline substitutions would tend to rigidify the 
peptide substrate and their presence might influence 
subsite occupancy by altering the conformation and/or 
restricting the flexibility of bound substrate. 
The influence of S’Z and other subsites on the specificity 
of PSA is reminiscent of the specificities of the closely 
related enzymes kallikrein and tonin. In porcine pancre- 
atic kallikrein, the X-ray crystal structure suggests that 
the sidechain of a substrate P2 tyrosine can insert 
between Tyr99 and Trp215 (chymotrypsin numbering) 
[28], and kinetic studies reveal that bulky residues at P2 
such as phenylalanine or tyrosine are preferred [29]. In 
addition, physiologically relevant cleavages of human 
kininogen by human tissue kallikrein occur at both 
Arg-Ser and Met-Lys bonds [30], revealing that permis- 
sive Sl specificity, similar to that observed for PSA, is 
required for proper processing of physiological substrates 
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Figure 5 
OH 
CBT val41 
Chemlstty & Biology 
Projected view of the consensus substrate 
peptide bound to the PSA. The consensus 
substrate peptide has purple bonds and blue 
residue numbers, whereas the PSA has 
orange bonds and black and red residue 
numbers. Atoms containing the letter Y in the 
P4 residue form the blocking acetyl group. 
The atom NT is the amidated group that 
blocks the P2’ carboxyl terminus. All other 
atoms are labeled as in PDB files with OG 
denoting y oxygen, CB denoting the 8 carbon, 
and CA denoting the CL carbon. Hydrogen 
bonds, as defined by the program HBPLUS 
[57], are drawn in green with the length of 
each bond (A) indicated. Red numbers 
indicate residues that are in direct hydrogen- 
bond contact with the substrate whereas the 
black residue numbers show those that are in 
van der Waals contact (contacts are 
represented by red spikes both on the 
substrate peptide and on the PSA). Highly 
conserved hydrogen bonds between the 
backbone of the substrate/inhibitor and the 
mainchain of PSA expected in a canonical 
protease-substrate/inhibitor complex are 
present in this model. These conserved, 
hydrogen bonds include interactions between 
residues P3 and 216, P2 and 214, Pl and 
193 and 195, P2’ and 41. In addition, a bond 
between the acetylated amino terminus of the 
P4 residue and the mainchain amide-NH of 
Glu218 is present in our model. This figure 
was plotted using LIGPLOT [58]. 
by tissue kallikrein. Similarly, tonin, which shares 53% 
homology with PSA, also has a broad Sl specificity. 
Tonin can cleave after Pl arginine, alanine, or phenylala- 
nine residues [31] and is capable of releasing angiotensin 
II, from angiotensinogen by cleaving a Phe-His bond 
[32]. An intriguing question is whether PSA, like kinino- 
gen or kallikrein, requires flexible recognition of Pl 
amino acids for proper physiological function or whether 
this trait is a remnant of its relatively recent divergence 
from kallikrein and tonin. 
The dependence of the identity of the Pl residue on amino 
acid context demonstrates an important caveat for studies 
of protease sp.ecificity that use substrate phage display 
technology. We would not have appreciated the possibility 
of shifting Pl specificity for individual substrates without 
performing detailed analytical and kinetic characterization 
of hydrolysis by PSA of peptide substrates containing 
amino acid sequences present in selected substrate phage 
clones. Although certainly informative, sequence align- 
ments of substrate phage alone cannot directly provide 
definitive qualitative, much less quantitative, information 
on protease selectivity. On the other hand, kinetic analysis 
of individual peptide substrates is severely limited by the 
small fraction of potential substrates that can be examined 
and by the solubility of individual peptides. Furthermore, 
in our studies it was the consensus peptide derived from 
phage display, not one of the individual selected 
sequences, that afforded the most efficiently hydrolyzed 
substrate. Only by using the two strategies together, then, 
is it possible to examine protease specificity both compre- 
hensively and quantitatively. 
Use of sequence preferences to refine a structural model 
for PSA-substrate recognition 
Several investigators have previously reported models for 
PSA [25,33,34], and one of these models has been 
deposited in the Protein Data Bank (lPFA.PDB) [25]. 
Attempts to dock the optimized, P4-P2’ consensus sub- 
strate SSYY&SG into this model, however, were unsuc- 
cessful, primarily due to significant steric clashes between 
the P’Z tyrosine residue of the substrate and the large 
insertion loop at position 9.5 (chymotrypsin numbering 
system) of PSA. 
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Figure 6 
Docking of the consensus substrate peptide to the PSA. The substrate 
peptide is drawn in purple from position P4 to P2’. PSA is represented 
as a red trace from all its Ca atoms. The molecular surface of PSA is 
colored according to the curvature of all the heavy atoms present in 
the model. The blue region of the PSA trace corresponds to the 11 
residue insertion, compared with chymotrypsin, between residues 95 
and 96 (chymotrypsin numbering system). Sidechains of residues that 
form the catalytic triad (Asp1 02, His57 and Serl95) are white. 
To gain additional insight into the molecular basis of sub- 
strate specificity for PSA, we constructed a new model of 
PSA bound to substrate (Figures 5-7). The known struc- 
ture of the closely related serine protease porcine tissue 
kallikrein [28], which exhibits 60% amino-acid identity to 
PSA, was chosen to begin homology modeling of PSA. It is 
generally believed that substrates and inhibitors bind in 
the active-site cleft of chymotrypsin family serine pro- 
teases in a single ‘canonical’ conformation characterized 
by formation of a short anti-parallel /3 sheet between the 
P3-Pl residues of the substrate or inhibitor and residues 
214-216 (chymotrypsin numbering) of the protease. This 
short anti-parallel p sheet contains three highly conserved 
hydrogen bonds: the amide-NH group of the Pl residue to 
the carbonyl group of Ser214, the carbonyl group of the P3 
residue to the amide-NH group of Gly216 and the amide- 
NH group of the P3 residue to the carbonyl group of 
Gly216. All three hydrogen bonds of the canonical anti- 
parallel p sheet are present in our PSA model, and all are 
within optimal distances. In addition, the carbonyl oxygen 
atom of the Pl residue of the consensus substrate extends 
into the oxyanion hole of PSA where, as expected, it forms 
hydrogen bonds with both the amide-NH of Gly193 and 
the amide-NH of Ser195. Because the amino terminus of 
the consensus substrate in the model is acetylated, a new 
hydrogen bond occurs between the carbonyl oxygen atom 
of the acetyl group and the amide-NH group of 61~1218. 
This new hydrogen bond suggests the pathway that the 
next residue (PS) of a proteinacious substrate might take. 
The backbone conformation of the docked peptide sub- 
strate makes a type VIa2 turn [35] at the PZ-Pl position. A 
type VIa2 turn is characterized by a pair of dihedral angles 
P-a, for residue i + 1 and i + 2. Every other residue of the 
substrate has an extended conformation (p region). 
Sidechains of all substrate residues are within the known 
rotamer library. The Cp atom of the P4 serine residue is in 
direct van der Waals contact with Trp215, a highly con- 
served residue, which suggests that peptides containing a 
P-branched amino acid at P4 might be poor substrates of 
PSA. The serine residue at position P3 is in hydrogen- 
bonding distance with the atoms 0~1 and 082 of Glu218 
of PSA, although the geometry is not ideal. The sidechain 
of the P3 serine residue is partially buried by this gluta- 
mate residue. The presence of an acidic amino acid at 
position 218 is unusual in the (chymo)trypsin serine pro- 
tease family [ZS]; consequently, these interactions might 
contribute to the specificity of PSA. 
The tyrosine residue at position P2 of the docked sub- 
strate fits into a pocket created by the large 95-96 loop of 
PSA. The phenol ring of the tyrosine lies against the imi- 
dazole ring of His57, a member of the catalytic triad. The 
P2 tyrosine is covered by the sidechain of Arg95, and the 
hydroxyl group of this tyrosine forms a hydrogen bond 
with the Nq2 group of Arg95G. Although Arg95G is 
expected to exhibit significant mobility due to the intrin- 
sic flexibility of the 95-96 loop of PSA, the location of this 
basic residue suggests that, as observed in this study, its 
affect on the position of a PZ basic residue would decrease 
catalysis, probably by perturbing the electrostatic poten- 
tial in the vicinity of the catalytic triad (Figure 7). 
The tyrosine at position Pl of the peptide substrate binds 
to the specificity pocket nicely. The Sl pocket of PSA is 
formed by residues 213-220, 189-192, and 225-228, and 
is closed by the PZ and P3 residues of the substrate itself. 
The sides of the Sl pocket are hydrophobic but the 
bottom of this pocket is polar, containing Oy atoms from 
Ser189 and Ser226 and a carbonyl group from Ser217. 
The tyrosine-OH group is within hydrogen-bonding dis- 
tance of both the Oy of Ser226 and the mainchain car- 
bony1 oxygen of SerZ.17. The inward side of the pocket is 
locked by a hydrogen bond between the Oy atom of 
Ser192 and the Oy atom of Ser226. It was postulated pre- 
viously [25] that the Sl binding pocket would prefer 
hydrophobic residues. Like hydrophobic residues such as 
phenylalanine or leucine, a tyrosine residue at Pl can 
form a large number of van der Waals contacts with sur- 
rounding PSA residues along the sides of the specificity 
pocket. Unlike these hydrophobic residues, however, a 
Pl tyrosine residue can also form the hydrogen-bonding 
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Figure 7 
Perturbation of the electrostatic potential of 
the Asp1 02-His57 interaction by a basic 
residue at the P2 position of a PSA 
substrate. Electrostatic potentials were 
calculated using Delphi (Version 3.0) [591 
and PARSE parameters [601 with a 129 
cubes grid, allowing a final resolution of 2.4 
grid point/A. Parameters used in these 
calculations were as follows: internal and 
external dielectric constants were 2 and 80, 
respectively, ionic strength was 150 mM, 
ionic exclusion radius was 2 A, and the probe 
radius for surface calculation was 1.4A. One 
focusing step was used (initial was 490/o, final 
was 980/o). The electrostatic potential was 
read into AVS (AVS, Waltham, MA) and 
mapped onto the molecular surface of 
residues 57 and 102. The PSA is drawn as a 
Ccc trace in pink with the 95-96 loop 
highlighted in cyan. The substrate peptide is 
drawn in green. In panel (a) the consensus 
substrate is shown with a tyrosine at position indicated by red. In (b) the electrostatic 
P2 whereas in (b) we replaced the residue potential in the vicinity of Asp1 02 is altered 
P2 by an arginine. Positive potential is due to juxtaposition of the buried P2 arginine 
indicated by blue and negative potential is from the substrate. 
interactions with residues at the bottom of the specificity 
pocket as described above. Because they are buried in 
the hydrophobic Sl pocket, these hydrogen-bonding 
interactions are expected to be strong. 
To test this hypothesis computationally, we mutated the 
consensus substrate peptide by replacing the tyrosine in 
Pl by either leucine, phenylalanine, isoleucine or methio- 
nine. We calculated the difference in the gas phase energy 
between the mutated and the consensus substrate using 
the CHARMMZ? all atom force field. We obtained the 
following positive differences in energy: 1.0, 12.3, 30.9, 
46.4 kcal/mol, for leucine, phenylalanine, isoleucine, and 
methionine mutants, respectively. Consistent with the 
observations of this study, the calculations predict that the 
consensus substrate is more energetically favorable than 
the mutated substrates. 
These calculations also suggest that, compared with tyro- 
sine, phenylalanine is strongly disfavored at Pl primarily 
due a loss of 10 kcal/mol from the electrostatic energy 
term. Finally, our calculations suggest that the large 
hydrophobic sidechains (isoleucine, phenylalanine, 
methionine) are more disfavored than the shorter leucine 
sidechain due to reductions in both the van der Waals and 
electrostatic energy terms. These results imply that the 
bottom of the Sl binding pocket is polar and, conse- 
quently, that large hydrophobic sidechains provide poor 
electrostatic complementarity in this pocket. The rank 
order of preference for the five amino acid residues 
observed at the Pl position of the selected, substrate 
phage is identical to that calculated using our new model, 
a result that provides support for the computational value 
of the model. 
The serine at position Pl’ of the docked, consensus sub- 
strate is in van der Waals contact with His57, suggesting 
that, as observed in the selected substrate sequences, 
small residues might be preferred at this position. The 
glycine residue at position PZ’ in the consensus substrate 
is bordered by Ser192, Gly193, Va141, Cys42, and Arg39. 
The carbonyl group of the P2’ glycine is within hydrogen- 
bonding distance of both the NE and Nql groups of 
Arg39. The size of the SZ’ pocket suggests that large 
residues would be poorly accommodated, an observation 
that is consistent with the substrate phage display results 
described above. 
Comparison of peptide digestion by PSA and chymotrypsin 
PSA shares with chymotrypsin a preference for recognition 
of hydrophobic amino acids at the Sl subsite. To put 
catalysis by PSA into better perspective relative to an 
enzyme known for its high activity and lack of sequence 
selectivity, we assayed hydrolysis of three substrate pep- 
tides III, XVI, and XXII by chymotrypsin and compared 
the kinetics of digestion to those observed using PSA 
(Table 5). These peptides were chosen because they 
varied from poor, III, to moderate, XVI, to highly labile, 
XXII, substrates for PSA. 
Hydrolysis of the peptides by PSA was more sequence 
dependent than hydrolysis by chymotrypsin, as k,,,/K, 
values for cleavage by PSA varied 1200-fold, whereas 
k,,,/K, values for cleavage by chymotrypsin varied by only 
3.6-fold. The cleavage of each peptide by chymotrypsin 
was more efficient than catalysis by PSA, with k,JK, 
values 24-4300-fold greater for chymotrypsin than for 
PSA. Relatively inefficient catalysis by PSA was reflected 
in both K, and k,,, values, with K, values for cleavage by 
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Table 5 
Comparison of hydrolysis of peptide substrates by PSA and chymotrypsin. 
PSA Chymotrypsin 
Substrate k cat k,at’k k,‘Km L,/Krr 
*(Pn ,... P3, P2, Pl JPl’, P2’, P3’,... Pn’) s-1 (h (M-’ s-1) Gh (M-’ s-‘) ChymolPSA 
Ill GSQQLYhNKQEGRD 0.037 14000 2.6 24 230 1.1 (lo)5 4300 
XVI GAGAPRASVYkGAG 3.3 7100 460 36 130 2.7 (1 0)5 590 
XXII GAGLRLSSYYJSGAG 0.83 270 3100 9.8 130 7.5 (lo)4 24 
*Positional nomenclature of subsite residues. Arrows denote the position of peptide bond hydrolysis as identified by mass spectral analysis. 
Calculated error values were between 13-31 O/o. 
PSA increased from Z-61-fold relative to values for chy- 
motrypsin, and k,,, values decreased 12-6.50-fold. The 
lower efficiency of PSA-mediated catalysis suggests that 
PSA is generally less able than chymotrypsin to bind sub- 
strate in a catalytically productive orientation, although 
the magnitude of the difference between PSA and chy- 
motrypsin is dependent on the precise amino-acid 
sequence of the substrate. 
The observation that, compared with chymotrypsin, PSA 
is a less efficient catalyst for peptide hydrolysis but pos- 
sesses a more sharply defined specificity is similar to 
results previously obtained by comparing peptide hydroly- 
sis by trypsin, tissue-type plasminogen activator (t-PA) 
[23], and urokinase-type plasminogen activator (u-PA) 
[24]. Like chymotrypsin, trypsin is a highly active protease 
with little preference for sequence beyond the Sl subsite, 
whereas t-PA and u-PA are highly selective enzymes that 
achieve selectivity in spite of substantial sequence iden- 
tity and overall structural similarity [36,37] with trypsin. 
Like PSA relative to chymotrypsin, t-PA and u-PA are 
much less active and much more selective towards 
peptide substrates than is trypsin. Furthermore, similar to 
correlations we observe for PSA, cleavage of peptides by 
u-PA or t-PA is characterized by higher K, and lower k,,, 
values than observed with trypsin. These parallels 
suggest, like u-PA and t-PA, PSA might possess restricted 
substrate specificity in viva, with the low activity of PSA 
towards most potential substrates being a physiologically 
important mechanism for controlling proteolysis. 
Our previous studies of optimal subsite occupancy for 
t-PA demonstrated that the most labile substrate 
sequences for this protease were not particularly selective 
and were also cleaved efficiently by u-PA [‘24]. To.isolate 
substrates that could discriminate between these two 
closely related mammalian plasminogen activators, we 
developed a new technique, substrate subtraction phage 
display, which included a subtraction step during the 
phage selection that removed substrates that were cleaved 
efficiently by u-PA [38]. Our observation that hydrolysis of 
selected peptides III, XVI, and XXII by chymotrypsin was 
more efficient than hydrolysis by PSA suggests that a 
similar approach may be required to isolate peptide sub- 
strates that are specific for PSA. An alternative approach to 
achieving PSA/chymotrypsin selectivity could take advan- 
tage of the relatively permissive Pl requirements of PSA, 
and Isaacs and coworkers [18] have previously demon- 
strated that molecules that include glutamine as a Pl 
residue are specific for hydrolysis by PSA relative to 
hydrolysis by chymotrypsin. 
Significance 
Prostate-specific antigen (PSA), a (chymo)trypsin family 
protease is an important marker for prostatic malignancy. 
Two independent approaches to defining protease speci- 
ficity, substrate phage display and iterative optimization of 
native substrates, converge on SS(Y/P)Y&G as a con- 
sensus sequence for efficient peptide hydrolysis by PSA. 
Although tyrosine is preferred as a Pl residue, non-P1 
residues also play an important role in defining labile sub- 
strates and can even cause otherwise disfavored amino 
acids to bind in the Sl pocket. Thus, the common charac- 
terization of the specificity of PSA as ‘chymotrypsin- 
like’ is insufficient and potentially misleading. 
Understanding of substrate preferences has allowed 
refinement of existing structural models fan PSA. The 
new model provides insight into the molecular determi- 
nants of the preference for tyrosine as a Pl residue and 
suggests that the P2 residue of a substrate or inhibitor fits 
into a pocket formed by a large insertion loop that is not 
present in most chymotrypsin family proteases. 
Elucidation of substrate sequence specificity for PSA will 
facilitate its use as a scaffold for engineering selective 
proteolysis and investigating the evolution of protease 
specificity. Such studies are particularly intriguing 
because the 78% identity between PSA and human glan: 
dular kallikrein [39], an enzyme specific for arginine at 
Pl, suggests that the kallikrein scaffold could be rela- 
tively adaptable and that it might be easier to alter the Pl 
specificity of PSA than has been the case with trypsin or 
chymotrypsin [40,41], where such efforts have required a 
relatively large number of point mutations and have com- 
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promised catalysis. In addition, the importance of recog- 
nition of the S2 and other subsites suggests that PSA has 
an extended substrate-binding site that provides multiple 
targets for the alteration of specificity by mutagenesis, 
further facilitating use of PSA as a starting point for the 
development of novel specificities by rational design or 
selection. 
Knowledge of substrate preferences for PSA should 
facilitate development of more sensitive assays for 
catalysis to complement existing immunoassays and 
enhance the diagnostic information that can be gained 
from analysis of PSA. Highly specific substrates for 
PSA should also guide design of inhibitors useful for 
probing the importance of PSA levels during tumor pro- 
gression and for the investigation of additional physiolog- 
ical functions of the enzyme in both cancerous and 
normal prostatic tissue. Inhibitors could also act as tight- 
binding targeting agents for delivering immunotoxins, or 
radioimaging agents to prostate tumors; additionally, 
PSA-directed prodrugs have recently been shown to be 
cytotoxic to PSA-producing cells 1421. 
Materials and methods 
Determination of the concentrations of active proteases 
Purified PSA was obtained from Calbiochem (La Jolla, CA). Purified chy- 
motrypsin and insulin 8 chain were obtained from Sigma (St. Louis, MO). 
The concentration of active PSA or chymotrypsin was determined by 
titration with 4-methylumbelliferyl p-(NNN-trimethylammonium)-cinnamate 
chloride (MUTMAC) (Sigma, St. Louis, MO) (431. The reaction of PSA 
with MUTMAC was too slow to be accurately quantitated by continuous 
measurement of the release of fluorescent material, so we measured the 
difference in fluorescence between the initial MUTMAC solution and the 
solution after complete labeling of PSA. Titration reactions were per- 
formed in buffer containing 50 mM Tris, pH 8.0, 10 mM CaCI,, and 0.1% 
Tween-20. Titration reactions were allowed to proceed to completion 
and fluorescent measurements were taken with a Perkin-Elmer LS50B 
Luminescence fluorometer with excitation and emission wavelengths of 
365 nm and 445 nm, respectively. Titration reactions with PSA were per- 
formed in a 30 ~1 volume for 10 min to ensure that all the enzyme had 
reacted and then diluted to 1 ml for fluorescent measurement. Calculated 
concentrations were similar regardless of the time allowed for labeling of 
PSA by MUTMAC and approximated the antigenic concentration of PSA 
determined by antibody labeling. 
Substrate phage display selection using PSA 
L 
Substrate phage panning of polyvalent phage has been described pre- 
viously [20,23,24]. For PSA, selection of positive phage was per- 
formed as follows: approximately 3(1O)‘O phage (33-45 l.rl of the 
fTC-LIB-N8 library) in a PSA compatible assay buffer (50 mM Tris 
pH 7.4, 100 mM NaCI, 10 mM CaCI,, 0.01 O/o Tween 20) was digested 
for 4 h at 37% with concentrations of PSA ranging from 
10-l 00 pg/ml. Total volume of each digest was 250 ~1. Reactions 
were then placed on ice, bovine serum albumin was added to 0.10/o, 
and 100 pg mAb 3-E7 was added. After 30 min on ice, 300 ul of Pan- 
sorbin cells (protein A-bearing Staphylococcus aureus, Calbiochem) 
were added and the resultant slurries were rocked at 4°C for 1 h. The 
mixtures were then centrifuged for 2 min and supernatants were recov- 
ered to repeat the Pansorbin cell adsorption step. Final supernatants 
were amplified overnight in Escherichia co/i K91 cells. A small aliquot 
of each final supernatant was used for titering on K91. 
Individual clones were selected from the titer plates, grown in 4 ml cul- 
tures and tested as PSA substrates by dot blot analysis as described 
previously [23,241. Four subsequent rounds of selection were per- 
formed. In round 2, phage were treated for one or four hours with 5 or 
20 pglml PSA. Round 3 libraries were treated for 1 h with 2.5, 5, or 
10 pglml PSA. Round 4 libraries were treated with one or two pg/ml 
PSA for 30 min or 1 h. In round 5 phage were digested for 5 or 10 min 
with 0.5 or 1 pg/ml PSA, and reactions were stopped by adding 15 ~1 
of 128 mM PMSF. 
One additional modification was added to the protocol for rounds 4 
and 5. Phage libraries were initially treated with the 3-E7 antibody mAb 
3-E7 (Gramsch Laboratories, Schwabhausen, Germany) and adsorbed 
to Pansorbin cells, and substrate phage were released by proteolytic 
cleavage. The resultant supernatants were then resubjected to Pan- 
sorbin cell adsorption. This technique was adopted to prevent accumu- 
lation of ‘nonreactive’ phage, which do not interact with mAb 3E-7 even 
before treatment with protease. These phage are normally selected 
along with substrate phage, and their accumulation typically limits the 
number of rounds of selection that can be performed. ‘Nonreactive’ 
phage have not yet been characterized comprehensively; it seems 
likely, however, that the randomized octamer in many of these phage is 
either efficiently digested by E. co/i proteases or interacts with the 3E-7 
epitope. Alternatively, nonreactive phage could have deleted or 
mutated the antibody epitope. Regardless of the mechanism by which 
the nonreactive phage escape recognition by mAb 3E-7, these phage 
were eliminated by the modification described above for the round 4 
and 5 selections. 
Kinetics of peptide cleavage 
Peptides were synthesized and purified as described previously [23,24]. 
Kinetic data were obtained by incubating varying concentrations of 
peptide with a constant enzyme concentration to achieve between 5 
and 20% cleavage of peptide during each reaction. Reactions were per- 
formed in 50 mM Tris, pH 8.0, 10 mM CaCI,, 0.1% Tween-20 as 
described previously [23,24]. The percentage of cleavage was corre- 
lated with the time of digestion to ensure that conditions were within the 
range of linear responsiveness for the assay. PSA concentrations varied 
between 50 nM and 200 nM. Peptide concentrations varied between 
100 PM and 12 mM and in all cases were chosen to surround K,. Both 
parent peptides and cleavage products were collected and character- 
ized by mass spectral analysis using a Voyager MALDI-TOF spectrome- 
ter (PerSeptive Biosystems). Data were interpreted by Eadie-Hofstee 
analysis. Statistical errors were calculated as described previously [44]. 
Modeling of PSA 
Sidechains of tissue kallikrein were replaced by those of PSA using the 
most favored rotamer conformation according to the library of Tuffery 
et al. 1451 (S.W.W. Chen and J.-L.P., unpublished observations). 
Sidechain conformations were minimized using the all atom force field 
CHARMM22 [46] in the X-PLOR package [47]. We used the conju- 
gate gradient method to minimize the resulting coordinates 1481, and 
we selected shifted electrostatic and switched van der Waals functions 
for nonbonded terms. The dielectric constant was set at 1 .O and the 
nonbonded cut off was 12 A with a cut on and a cut off of 8.5 A and 
11 A, respectively. Hydrogens were systematically rebuilt before each 
minimization step using the program HBUILD available in X-PLOR [49]. 
The single deletion in PSA, compared with tissue kallikrein, occurs at 
position 146A-147 (chymotrypsin numbering) in the ‘autolysis loop’. 
Consequently, the autolysis loop of the PSA model was built by start- 
ing with the corresponding region of tissue kallikrein (2kai,pdb, 
2pka.pdb) and manually resolving the two-residue deletion using 
Turbo-Frodo. All sidechains were minimized, excluding the electrostatic 
term, until the norm of the gradient reached 0.5. 
Compared with the archetypal serine protease trypsin, PSA, kallikrein 
and tonin have an insertion of 11 residues between positions 95 and 96 
(chymotrypsin numbering system). We extracted a portion of this loop 
(residues 95C-96) from the model of Villoutreix and colleagues [25] and 
inserted it into our current model. We then inserted residues 95-95B 
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from the corresponding loop in the tonin structure into our model and 
manually adjusted the dihedral angles in this region to connect the two 
loop segments. Following manual adjustment of these dihedral angles, 
the 95-96 loop was minimized using parameters described above. 
We used the new PSA model to dock the consensus substrate 
sequence SSYY&SG in the ‘canonical’ conformation that has been 
observed in many protease/inhibitor complexes, including the complex 
between hirustatin and kallikrein [50]. The sidechains of residues 
27-32 of hirustatin (VHCRIR) from the hirustatinlkallikrein complex 
(1 hia.pdb) were mutated to match the consensus PSA substrate 
SSYYJSG using the program Xfit [51], and this six amino-acid 
sequence was then docked into the PSA model. We used the reactive 
center loop of hirustatin for this procedure for two reasons. First, unlike 
many ‘standard’ protease inhibitors, hirustatin does not contain proline 
in its reactive center loop and, second, hirustatin inhibits kallikrein, the 
serine protease that is most closely related to PSA. Chi dihedral angles 
of the tyrosines at position Pl and P2 were manually adjusted. All 
sidechains of PSA and the docked substrate were optimized, excluding 
the electrostatic term, until the norm of the gradient reached 0.5. The 
chirality of residues 20, 91 and 221 were adjusted in Turbo-Frodo as 
recommended by a PROCHECK output [52]. 
To optimize the geometry of the large 95-96 loop of PSA in the 
docked complex, we performed a molecular dynamic simulation at 
300K for 50 ps to explore more favorable conformational states. We 
used the Verlet algorithm [53] with a temperature coupling method 
according to Berendsen et al. [54]. Initial velocities were obtained from 
a Maxwellian distribution. During the simulation, the integration step 
was 1 fs, bond distances were restrained by the shake method [55], 
the electrostatic term was turned off, and other nonbonded parameters 
were identical to those used during previous minimizations. Examina- 
tion of the Ramachandran map produced by the PROCHECK program 
[521 indicated that this procedure substantially improved the geometry 
of the final conformation of the new PSA model. Finally, we minimized 
all atoms of the consensus substrate peptide and obtained the final 
docking conformation shown in Figure 4. 
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